Kringle Pharma, Inc. (TYO:4884)
Japan · Delayed Price · Currency is JPY 345.00
+12.00 (3.60%)
Aug 6, 2026, 3:10 PM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 2.46 billion as of August 5, 2026. Its market cap has decreased by -27.96% in one year.
Market Cap
2.46B
Enterprise Value
874.54M
Revenue
73.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
345.00
ChartMarket Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has decreased from 5.09B to 2.46B, a decrease of -51.58%. That is a compound annual growth rate of -12.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 2.46B | -12.83% |
| Dec 30, 2025 | 2.82B | -52.49% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 5.20B |
| D. Western Therapeutics Institute | 4.60B |
| Kohjin Bio | 4.52B |
| TMS Co., Ltd. | 4.51B |
| Ribomic | 4.24B |
| Transgenic Group | 3.56B |
| Human Metabolome Technologies | 3.29B |
| Modalis Therapeutics | 3.11B |